Lung Cancer Therapeutics Market Report

Global and Region Lung Cancer Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：200
  • REPORT CODE：GMM892188
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Lung Cancer Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Lung Cancer Therapeuticsmarket, defines the market attractiveness level of Lung Cancer Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Lung Cancer Therapeutics industry, describes the types of Lung Cancer Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Lung Cancer Therapeutics market and the development prospects and opportunities of Lung Cancer Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Lung Cancer Therapeutics market in Chapter 13.

    By Player:

    • Novartis AG (Switzerland)

    • Bristol-Myers Squibb Company (US)

    • F Hoffmann-La Roche Ltd (Switzerland)

    • Eli Lilly and Company (US)

    • Pfizer Inc (US)

    • Merck & Co, Inc (US)

    • Sanofi (France)

    By Type:

    • Chemotherapy

    • Targeted therapy

    • Drugs

    • Surgery

    • Radiotherapy

    By End-User:

    • Treatment Of Early and Middle Lung Cancer

    • Treatment Of Advanced Lung Cancer

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Lung Cancer Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Lung Cancer Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Lung Cancer Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Lung Cancer Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Lung Cancer Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Lung Cancer Therapeutics Consumption (2017-2022)

    • 7.2 United States Lung Cancer Therapeutics Consumption (2017-2022)

    • 7.3 Europe Lung Cancer Therapeutics Consumption (2017-2022)

    • 7.4 China Lung Cancer Therapeutics Consumption (2017-2022)

    • 7.5 Japan Lung Cancer Therapeutics Consumption (2017-2022)

    • 7.6 India Lung Cancer Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Lung Cancer Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Lung Cancer Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Lung Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Lung Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Lung Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Lung Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Lung Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Lung Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Lung Cancer Therapeutics Consumption Forecast (2022-2028)

    9 Global Lung Cancer Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Lung Cancer Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Targeted therapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Surgery Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Radiotherapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Lung Cancer Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Treatment Of Early and Middle Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Treatment Of Advanced Lung Cancer Consumption and Growth Rate (2017-2022)

    10 Global Lung Cancer Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Lung Cancer Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Targeted therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Surgery Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Radiotherapy Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Lung Cancer Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Treatment Of Early and Middle Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Treatment Of Advanced Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    11 Global Lung Cancer Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Lung Cancer Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Lung Cancer Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Lung Cancer Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Lung Cancer Therapeutics Market Competitive Analysis

    • 14.1 Novartis AG (Switzerland)

      • 14.1.1 Novartis AG (Switzerland) Company Details

      • 14.1.2 Novartis AG (Switzerland) Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Novartis AG (Switzerland) Lung Cancer Therapeutics Product and Service

    • 14.2 Bristol-Myers Squibb Company (US)

      • 14.2.1 Bristol-Myers Squibb Company (US) Company Details

      • 14.2.2 Bristol-Myers Squibb Company (US) Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bristol-Myers Squibb Company (US) Lung Cancer Therapeutics Product and Service

    • 14.3 F Hoffmann-La Roche Ltd (Switzerland)

      • 14.3.1 F Hoffmann-La Roche Ltd (Switzerland) Company Details

      • 14.3.2 F Hoffmann-La Roche Ltd (Switzerland) Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 F Hoffmann-La Roche Ltd (Switzerland) Lung Cancer Therapeutics Product and Service

    • 14.4 Eli Lilly and Company (US)

      • 14.4.1 Eli Lilly and Company (US) Company Details

      • 14.4.2 Eli Lilly and Company (US) Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Eli Lilly and Company (US) Lung Cancer Therapeutics Product and Service

    • 14.5 Pfizer Inc (US)

      • 14.5.1 Pfizer Inc (US) Company Details

      • 14.5.2 Pfizer Inc (US) Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Pfizer Inc (US) Lung Cancer Therapeutics Product and Service

    • 14.6 Merck & Co, Inc (US)

      • 14.6.1 Merck & Co, Inc (US) Company Details

      • 14.6.2 Merck & Co, Inc (US) Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck & Co, Inc (US) Lung Cancer Therapeutics Product and Service

    • 14.7 Sanofi (France)

      • 14.7.1 Sanofi (France) Company Details

      • 14.7.2 Sanofi (France) Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sanofi (France) Lung Cancer Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Lung Cancer Therapeutics

    • Figure Lung Cancer Therapeutics Picture

    • Table Global Lung Cancer Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Lung Cancer Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Lung Cancer Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Lung Cancer Therapeutics Consumption by Country (2017-2022)

    • Figure United States Lung Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Lung Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Lung Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Lung Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Lung Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Lung Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Cancer Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Lung Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Lung Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Lung Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Lung Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Lung Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Lung Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Targeted therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Surgery Consumption and Growth Rate (2017-2022)

    • Figure Global Radiotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Treatment Of Early and Middle Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Treatment Of Advanced Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Targeted therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Treatment Of Early and Middle Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Treatment Of Advanced Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Lung Cancer Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Lung Cancer Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Novartis AG (Switzerland) (Foundation Year, Company Profile and etc.)

    • Table Novartis AG (Switzerland) Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG (Switzerland) Lung Cancer Therapeutics Product and Service

    • Table Bristol-Myers Squibb Company (US) (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company (US) Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company (US) Lung Cancer Therapeutics Product and Service

    • Table F Hoffmann-La Roche Ltd (Switzerland) (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd (Switzerland) Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd (Switzerland) Lung Cancer Therapeutics Product and Service

    • Table Eli Lilly and Company (US) (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company (US) Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company (US) Lung Cancer Therapeutics Product and Service

    • Table Pfizer Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc (US) Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc (US) Lung Cancer Therapeutics Product and Service

    • Table Merck & Co, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc (US) Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc (US) Lung Cancer Therapeutics Product and Service

    • Table Sanofi (France) (Foundation Year, Company Profile and etc.)

    • Table Sanofi (France) Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi (France) Lung Cancer Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US